Anti-herpesvirus prophylaxis versus placebo, no treatment or pre-emptive treatment in hemato-oncological malignancies

We will assess the effects of anti-herpes drugs in hemato-oncological patients comparing prophylaxis versus placebo, no treatment or pre-emptive treatment.

This is a protocol.